Contribution of extracellular enzymes to Staphylococcus aureus biofilm development
胞外酶对金黄色葡萄球菌生物膜发育的贡献
基本信息
- 批准号:10461797
- 负责人:
- 金额:$ 45.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenosineAnti-Inflammatory AgentsAntibioticsBehaviorBiological MarkersCarbonCatabolismCell physiologyCollaborationsDNADefectDevelopmentDevicesDigestionDisaccharidesDiseaseEnvironmentEnzymesExcisionForeign BodiesGene ExpressionGenus staphylococcusGlycosaminoglycansGrowthHealthcare SystemsHumanHyaluronanHyaluronidaseImmuneIn VitroInfectionInflammationInflammatoryInnovative TherapyJoint ProsthesisKnock-outLabelMetabolicMetabolismMicrobial BiofilmsMutationNatureNutrientNutritionalNutritional statusPathway interactionsPatient-Focused OutcomesPatientsPhenotypePolymersProductionPropertyRegulationReportingResistanceRoleSchemeSiteSourceStaphylococcus aureusStaphylococcus aureus infectionSynovial FluidSystemTestingbioimagingcell communitychemotherapydefined contributionexoenzymeextracellularfollow-upgenetic analysishealth care settingsinhibitorjoint infectionmetabolomicsmutantnucleasepathogenic bacteriasensortranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Staphylococcus aureus is one of the most problematic bacterial pathogens in our healthcare settings. S. aureus
can survive and persist in the host by developing into an encased community of cells called a biofilm, and
numerous studies have demonstrated that biofilms are resistant to host immune defenses and chemotherapies.
Our central PPG hypothesis is that S. aureus biofilm development creates unique metabolic niches that promote
an immune suppressive environment. In this proposal (Project 3), we are focusing on the contribution of S.
aureus extracellular enzymes to biofilm growth and maturation, persistence in the host, and ultimately
dissemination to a new site. Of the many enzymes that S. aureus secretes, we will prioritize hyaluronidase (HysA)
and nuclease (Nuc1), as they have commonalities in biofilm-host interaction phenotypes and regulatory
schemes. We recently demonstrated that hyaluronan accumulates in an S. aureus biofilm infection and that
HysA can degrade this host glycosaminoglycan to disaccharides (HA-DS). Our preliminary studies indicate that
HA-DS can serve as a carbon source through an unknown catabolic pathway, and this disaccharide has
additional anti-inflammatory properties that could be contributing to the persistent nature of S. aureus biofilm
infections. In Specific Aim 1, we will determine the role and regulation of hyaluronan metabolism in S. aureus
biofilm maturation. We will characterize the HA-DS catabolic pathway using genetic analysis and labeling studies
in collaboration with the Metabolomics Core. We will also test catabolic pathway knockouts in biofilm maturation
and foreign-body infections, and investigate the contribution of CodY and CcpA to regulation of hyaluronan
catabolism. Additionally, S. aureus will be grown on HA-DS and RNAseq performed to identify global
transcriptomic changes. In Specific Aim 2, we will investigate how S. aureus enzymatic degradation of host
polymers impacts the biofilm anti-inflammatory state. In collaboration with Dr. Tammy Kielian (PPG Project 4),
we will assess the effect of HA-DS, as well as Nuc1 and HysA enzymes and their regulators, on immune cell
function. We will also determine the impact of HA-DS and HysA inhibitors on biofilm infection, and test whether
HA-DS is a biomarker for S. aureus in human synovial fluid from patients with prosthetic joint infection (PJI). In
Specific Aim 3, we will examine S. aureus exo-enzyme regulation and function in biofilm dispersal. We
hypothesize that CodY controls dissemination from S. aureus biofilms in an enzyme and nutrient dependent
manner. We will investigate the contribution of Nuc1 and HysA, along with CodY and SaeRS regulators, to biofilm
dispersal in vitro and during foreign body infection. We will also examine the impact of nutritional status on CodY
activity during biofilm formation and dispersal in collaboration with Dr. Ken Bayles (PPG Project 1) and the
Bioimaging Core. Finally, we will determine the role of aureusimine molecules in S. aureus biofilm development.
Collectively these studies will define the contribution of S. aureus exo-enzymes to biofilm metabolism,
development and persistence, potentially leading to innovative therapies for biofilm infections.
项目摘要
金黄色葡萄球菌是我们医疗保健环境中最有问题的细菌病原体之一。S.金黄色
可以通过发展成被称为生物膜的封闭细胞群落而在宿主中存活和持续存在,并且
许多研究已经证明生物膜对宿主免疫防御和化疗具有抗性。
我们的中心PPG假设是S。金黄色葡萄球菌生物膜的发展创造了独特的代谢生态位,
免疫抑制环境在本提案(项目3)中,我们关注的是S。
金黄色葡萄球菌胞外酶对生物膜生长和成熟的影响,在宿主中的持久性,
传播到新网站。在S.金黄色葡萄球菌分泌,我们将优先透明质酸酶(HysA)
和核酸酶(Nuc 1),因为它们在生物膜-宿主相互作用表型和调节
阴谋我们最近证实透明质酸在S.金黄色葡萄球菌生物膜感染,
HysA可以将该宿主糖胺聚糖降解为二糖(HA-DS)。我们的初步研究表明,
HA-DS可以通过未知的分解代谢途径作为碳源,这种二糖具有
额外的抗炎特性可能有助于S.金黄色葡萄球菌生物膜
感染.在具体目标1中,我们将确定透明质酸代谢在S.金黄色
生物膜成熟我们将使用遗传分析和标记研究来表征HA-DS分解代谢途径
与代谢组学核心合作。我们还将测试生物膜成熟中的分解代谢途径敲除
和异物感染,并研究CodY和CcpA对透明质酸调节的贡献
猫此外,S.金黄色葡萄球菌将在HA-DS上生长,并进行RNAseq以鉴定全球
转录组学变化。在具体目标2中,我们将研究S。金黄色葡萄球菌酶降解宿主
聚合物影响生物膜抗炎状态。与Tammy Kielian博士(PPG项目4)合作,
我们将评估HA-DS以及Nuc 1和HysA酶及其调节剂对免疫细胞的影响,
功能我们还将确定HA-DS和HysA抑制剂对生物膜感染的影响,并测试是否
HA-DS是S.金黄色葡萄球菌的人关节炎患者的关节液中的人工关节感染(PJI)。在
具体目标3,我们将检查S。金黄色葡萄球菌胞外酶在生物膜分散中的调节和功能。我们
假设CodY控制S.金黄色葡萄球菌生物膜中的酶和营养依赖
方式我们将研究Nuc 1和HysA沿着CodY和SaeRS调节剂对生物膜的贡献,
在体外和异物感染期间分散。我们还将研究营养状况对CodY的影响
与Ken Bayles博士(PPG项目1)和
生物成像核心。最后,我们将确定aureusimine分子在S。金黄色葡萄球菌生物膜形成。
总的来说,这些研究将确定S。金黄色葡萄球菌胞外酶对生物膜代谢的影响,
发展和持久性,可能导致生物膜感染的创新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tammy L Kielian其他文献
Tammy L Kielian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tammy L Kielian', 18)}}的其他基金
Modulating granulocytic myeloid-derived suppressor cell (G-MDSC) metabolic activity to promote Staphylococcus aureus biofilm clearance
调节粒细胞骨髓源性抑制细胞 (G-MDSC) 代谢活性以促进金黄色葡萄球菌生物膜清除
- 批准号:
10738662 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection
T细胞先天免疫串扰调节金黄色葡萄球菌开颅感染
- 批准号:
10590634 - 财政年份:2022
- 资助金额:
$ 45.33万 - 项目类别:
Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection
开颅手术相关生物膜感染期间促进金黄色葡萄球菌持续存在的免疫机制
- 批准号:
9896877 - 财政年份:2018
- 资助金额:
$ 45.33万 - 项目类别:
Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection
开颅手术相关生物膜感染期间促进金黄色葡萄球菌持续存在的免疫机制
- 批准号:
10375439 - 财政年份:2018
- 资助金额:
$ 45.33万 - 项目类别:
Therapeutic targeting of aberrant glial function during Juvenile Batten Disease
幼年巴顿病期间异常神经胶质功能的治疗靶向
- 批准号:
8788453 - 财政年份:2014
- 资助金额:
$ 45.33万 - 项目类别:
Therapeutic targeting of aberrant glial function during Juvenile Batten Disease
幼年巴顿病期间异常神经胶质功能的治疗靶向
- 批准号:
8660113 - 财政年份:2014
- 资助金额:
$ 45.33万 - 项目类别:
Contribution of extracellular enzymes to Staphylococcus aureus biofilm development
胞外酶对金黄色葡萄球菌生物膜发育的贡献
- 批准号:
10665029 - 财政年份:2009
- 资助金额:
$ 45.33万 - 项目类别:
The Role of Nuclease in Biofilm Development and Disease
核酸酶在生物膜发育和疾病中的作用
- 批准号:
7750239 - 财政年份:2009
- 资助金额:
$ 45.33万 - 项目类别:
Innate Immune Response to S. aureus Biofilm
对金黄色葡萄球菌生物膜的先天免疫反应
- 批准号:
10665032 - 财政年份:2009
- 资助金额:
$ 45.33万 - 项目类别:
相似国自然基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
- 批准号:82074359
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
- 批准号:81570244
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
- 批准号:81171113
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
- 批准号:
10929664 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
- 批准号:
23K14685 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
- 批准号:
10679989 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
- 批准号:
23K07566 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
- 批准号:
10760676 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
- 批准号:
10605737 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
- 批准号:
2319114 - 财政年份:2023
- 资助金额:
$ 45.33万 - 项目类别:
Standard Grant
The Biology of Microglia: Adenosine A3 Receptor Suppression
小胶质细胞的生物学:腺苷 A3 受体抑制
- 批准号:
RGPIN-2019-06289 - 财政年份:2022
- 资助金额:
$ 45.33万 - 项目类别:
Discovery Grants Program - Individual
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
- 批准号:
573323-2022 - 财政年份:2022
- 资助金额:
$ 45.33万 - 项目类别:
University Undergraduate Student Research Awards